Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MOHSEN S ARANI

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1821097072
CMS profile
127522
Location
THE WOODLANDS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$14,017.56

417 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $8,964.58 404
Consulting Fee $4,693.50 8
Education $359.48 5

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
OnMark, Inc. $1,742.02 7
Janssen Scientific Affairs, LLC $1,635.00 1
Regeneron Healthcare Solutions, Inc. $1,050.80 4
US Oncology Corporate, Inc. $855.59 5
Janssen Biotech, Inc. $812.32 19
Gilead Sciences, Inc. $657.91 12
Amgen Inc. $463.00 22
Novartis Pharmaceuticals Corporation $453.10 29
E.R. Squibb & Sons, L.L.C. $376.19 29
GlaxoSmithKline, LLC. $342.12 22
Celgene Corporation $295.85 15
AstraZeneca Pharmaceuticals LP $280.22 13
McKesson Specialty Care Distribution, LLC $278.42 3
Mylan Institutional Inc. $273.14 10
Daiichi Sankyo Inc. $269.60 7
Astellas Pharma US Inc $260.23 14
GENZYME CORPORATION $257.18 13
Pharmacyclics LLC, An AbbVie Company $257.12 11
Merck Sharp & Dohme LLC $247.64 14
PFIZER INC. $225.58 20
Eisai Inc. $181.89 11
Seagen Inc. $175.13 11
Blueprint Medicines Corporation $165.91 7
Genentech USA, Inc. $163.17 6
AVEO Pharmaceuticals, Inc. $136.26 7
Incyte Corporation $135.95 10
Alexion Pharmaceuticals, Inc. $130.59 7
Genmab U.S., Inc. $114.57 1
Lilly USA, LLC $108.64 5
Stemline Therapeutics Inc. $102.75 5
MorphoSys, US Inc. $101.44 5
Octapharma USA, Inc. $100.57 2
Apellis Pharmaceuticals, Inc. $92.79 3
Puma Biotechnology, Inc. $84.68 5
Spectrum Pharmaceuticals Inc. $80.22 4
PharmaEssentia USA Corporation $67.43 3
Celltrion USA Inc. $67.37 3
TAIHO ONCOLOGY, INC. $67.10 4
Karyopharm Therapeutics Inc. $64.04 4
Boehringer Ingelheim Pharmaceuticals, Inc. $61.64 3
Takeda Pharmaceuticals U.S.A., Inc. $60.31 3
Mirati Therapeutics, Inc. $58.64 3
Coherus Biosciences Inc. $56.89 4
Ipsen Biopharmaceuticals, Inc $52.79 3
Emmaus Medical, Inc. $51.37 3
ADC Therapeutics America, Inc. $48.53 2
Boston Scientific Corporation $48.13 1
Sumitomo Pharma America, Inc. $46.01 2
AbbVie Inc. $38.60 2
Helsinn Therapeutics (U.S.), Inc. $35.30 2
Pharmacosmos Therapeutics Inc. $32.81 2
Biocon Biologics Inc $21.72 1
CTI BioPharma Corp. $20.79 1
Verity Pharmaceuticals Inc. $20.75 1
Kyowa Kirin, Inc. $20.63 1
Adaptive Biotechnologies Corporation $20.17 1
Immunocore Limited $19.41 1
Bayer Healthcare Pharmaceuticals Inc. $18.88 1
ImmunoGen, Inc. $18.56 1
Pharming Healthcare, Inc. $17.26 1
BeiGene USA, Inc. $16.82 1
Jazz Pharmaceuticals Inc. $16.55 1
SOBI, INC $14.85 1
Kite Pharma, Inc. $13.39 1
EMD Serono, Inc. $13.23 1

Page 7 of 9; records 301–350 of 417 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MOHSEN S ARANI

NPI 1821097072 · CMS profile ID 127522

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

THE WOODLANDS, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 7 of 9; records 301–350 of 417 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1821097072?year=2023&recipient=provider&page=7#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MOHSEN S ARANI, NPI 1821097072, CMS profile ID 127522. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 7 of 9; records 301–350 of 417 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1821097072?year=2023&recipient=provider&page=7#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). MOHSEN S ARANI, NPI 1821097072, CMS profile ID 127522. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 7 of 9; records 301–350 of 417 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1821097072?year=2023&recipient=provider&page=7#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
MOHSEN S ARANI, NPI 1821097072, CMS profile ID 127522, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 7 of 9; records 301–350 of 417 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1821097072?year=2023&recipient=provider&page=7#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

417 matching records · $14,017.56 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 417 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 301–350 of 417.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Celltrion USA Inc. $13.5303/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044120733 CMS
E.R. Squibb & Sons, L.L.C. $10.8803/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015914327 CMS
GlaxoSmithKline, LLC. $26.3003/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002091417 CMS
Gilead Sciences, Inc. $96.7503/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025524359 CMS
Gilead Sciences, Inc. $17.8003/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025902041 CMS
Incyte Corporation $23.5203/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044419137 CMS
Janssen Biotech, Inc. $22.3303/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988754297 CMS
Celgene Corporation $24.0303/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015914335 CMS
Janssen Scientific Affairs, LLC $1,635.0003/28/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988761717 CMS
Helsinn Therapeutics (U.S.), Inc. $18.1203/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058018815 CMS
Merck Sharp & Dohme LLC $18.8103/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048401259 CMS
PFIZER INC. $9.9803/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050660031 CMS
SOBI, INC $14.8503/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1038076311 CMS
Apellis Pharmaceuticals, Inc. $30.2903/24/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056370507 CMS
Janssen Biotech, Inc. $21.1003/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988754305 CMS
E.R. Squibb & Sons, L.L.C. $13.0903/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015914331 CMS
Janssen Biotech, Inc. $19.4003/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988754301 CMS
Novartis Pharmaceuticals Corporation $2.1403/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991734827 CMS
PFIZER INC. $15.2503/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049137247 CMS
Novartis Pharmaceuticals Corporation $18.3303/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991734775 CMS
PharmaEssentia USA Corporation $22.2503/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059315475 CMS
Eisai Inc. $21.7203/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050450201 CMS
MorphoSys, US Inc. $23.8303/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060328763 CMS
PharmaEssentia USA Corporation $22.2603/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059315469 CMS
Novartis Pharmaceuticals Corporation $12.3303/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991734771 CMS
Amgen Inc. $16.6103/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020644551 CMS
Eisai Inc. $24.2003/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023324217 CMS
Lilly USA, LLC $19.9903/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031945391 CMS
Merck Sharp & Dohme LLC $15.8703/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048401261 CMS
AbbVie Inc. $22.0103/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996158559 CMS
TAIHO ONCOLOGY, INC. $20.1103/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055225697 CMS
Octapharma USA, Inc. $49.7803/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042716573 CMS
Alexion Pharmaceuticals, Inc. $16.9103/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017019949 CMS
Amgen Inc. $15.2303/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020644543 CMS
Daiichi Sankyo Inc. $24.1703/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006356879 CMS
AstraZeneca Pharmaceuticals LP $16.9603/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012102187 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.8803/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000509749 CMS
Mylan Institutional Inc. $23.9903/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1039004959 CMS
Octapharma USA, Inc. $50.7903/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042716565 CMS
Pharmacyclics LLC, An AbbVie Company $21.9103/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998281237 CMS
GENZYME CORPORATION $11.3203/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049916335 CMS
Eisai Inc. $14.6303/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1023324213 CMS
Novartis Pharmaceuticals Corporation $13.1003/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991734815 CMS
Celgene Corporation $14.5802/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015914319 CMS
Sumitomo Pharma America, Inc. $29.6102/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031020769 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.8602/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055335877 CMS
Janssen Biotech, Inc. $13.4102/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988754299 CMS
Celgene Corporation $17.2002/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015914299 CMS
E.R. Squibb & Sons, L.L.C. $12.3402/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015914315 CMS
PFIZER INC. $16.7802/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050700269 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $23,753.83 242
PY2020 $15,215.54 172
PY2021 $11,242.29 277
PY2022 $26,904.11 377
PY2023 $14,017.56 417
PY2024 $30,225.60 363
PY2025 $9,837.92 354

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $15,744.00 5

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

5 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Genentech, Inc. $1,400.00 11/14/2024 Non-covered Recipient Entity
MILLENNIUM RESEARCH AND CLINICAL DEVELOPMENT LLC
Phase III study of giredestrant everolimus vs everolimus exemestane in ER HER2 locally adv or mBC No dispute reported 06/30/2026 1133404376
Principal investigator 1 Genentech, Inc. $528.00 10/08/2024 Non-covered Recipient Entity
MILLENNIUM RESEARCH AND CLINICAL DEVELOPMENT LLC
Phase III study of giredestrant everolimus vs everolimus exemestane in ER HER2 locally adv or mBC No dispute reported 06/30/2026 1133404374
Principal investigator 1 Genentech, Inc. $9,033.00 09/18/2024 Non-covered Recipient Entity
MILLENNIUM RESEARCH AND CLINICAL DEVELOPMENT LLC
Phase III study of giredestrant everolimus vs everolimus exemestane in ER HER2 locally adv or mBC No dispute reported 06/30/2026 1133404372
Principal investigator 1 Genentech, Inc. $267.00 07/16/2024 Non-covered Recipient Entity
MILLENNIUM RESEARCH AND CLINICAL DEVELOPMENT LLC
Phase III study of giredestrant everolimus vs everolimus exemestane in ER HER2 locally adv or mBC No dispute reported 06/30/2026 1133404370
Principal investigator 1 Genentech, Inc. $4,516.00 04/04/2024 Non-covered Recipient Entity
MILLENNIUM RESEARCH AND CLINICAL DEVELOPMENT LLC
Phase III study of giredestrant everolimus vs everolimus exemestane in ER HER2 locally adv or mBC No dispute reported 06/30/2026 1133404368